Express Scripts vs. FTC: The Role of Pharmacy Middlemen in Drug Costs
Pharmacy Middlemen Under Fire
In a bold move, Express Scripts has initiated a lawsuit against the FTC, fueled by a controversial report. The FTC's July publication titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies” has sparked significant dialogue about the pricing structures of pharmaceuticals.
Key Points of Contention
- The FTC's report claims that pharmacy benefit managers are primarily responsible for escalating drug prices.
- Express Scripts counters that these claims misrepresent the role of middlemen in the pharmacy landscape.
- This legal action illustrates the ongoing debate about transparency and pricing in prescription medication.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.